Navigation Links
CMV Vaccine Prototype Successfully Tested in Guinea Pigs

Researchers have developed an experimental vaccine that reduces stillbirths of rodents born to mothers infected with cytomegalovirus// (CMV). This virus also causes mental retardation and hearing loss in newborn children infected in early fetal life. The National Institutes of Health funded this research.

Estimates place the number of U.S. children born with CMV each year at about 40,000, and there is no vaccine or treatment for pregnant women who have the infection. In a 2000 report, the Institute of Medicine of the National Academy of Sciences listed as a top priority the development of a vaccine to prevent cytomegalovirus during pregnancy.

"An effective CMV vaccine for women of childbearing age could greatly reduce the disability caused by the virus," said Duane Alexander, M.D., Director of the NICHD, the NIH institute that funded the study. "A prototype vaccine is the first step in protecting newborns against the most common viral disease of newborns in the developed world."

Female guinea pigs given the CMV vaccine before becoming pregnant gave birth to fewer dead pups and were less likely to transmit the infection to their offspring than were female guinea pigs not receiving the vaccine.

The vaccinated group (10 litters) produced 28 live pups and 4 dead pups—a mortality rate of 13 percent. The control group (8 litters), which received a vaccine for the flu, produced 9 live pups and 12 dead pups—a mortality rate of 57 percent.

The surviving pups weighed more than the pups of mothers that had not received the CMV vaccination before becoming pregnant. The vaccine greatly reduced the total amount of virus found in the mothers’ blood. The vaccine in the study was developed in collaboration with researchers at AlphaVax, Inc.

Background

CMV is a common viral infection related to the herpes virus and often causes few or no symptoms, according to the National Institute on Deafness and Ot
'"/>




Page: 1 2 3

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
(Date:7/23/2008)...to Meet the Financing Needs of European and ...-, NEW YORK, July 24 /PRNewswire/ -- Paul Capital... has been promoted to Partner. Based in Paul,Capit... sourcing,evaluating and negotiating European and... Paul Capital Healthcare funds., "Since he joined...
(Date:7/23/2008)... /PRNewswire/ -- MediVoice(R), LLC, the,world,s fi...and,e-Prescribing, has formed a strategic partners...ractive, web-based, patient-centered health record...integrate and market its,mobile voice-activation s...) system., "MediVoice is pleased to develop a str...
(Date:7/23/2008)...wire/ -- Philip J. Dwyer, president and CEO,of the... before the U.S.,Senate Health, Education, Labor, ...nd Families today to call for increased funds for ...ed at YMCAs across the nation, that will,help redu...on behalf of the more than 2,600 YMCAs, that -- fo...
(Date:7/23/2008)...gration and Naturalization ready at Passport ...y 23 /PRNewswire/ -- New vaccine requirements will...sa for entry into the U.S. and,anyone seeking adju...ts,must show proof of vaccinations against vaccine...Advisory Committee on Immunization Practices.,Pass...
Breaking Medicine News(10 mins):Health News:Paul Capital Partners Promotes Ken Macleod To Partner 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 3Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 2Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 3Health News:YMCA Calls on Senate to Fund Community-Based Solutions to Address Childhood Obesity Crisis 2Health News:YMCA Calls on Senate to Fund Community-Based Solutions to Address Childhood Obesity Crisis 3Health News:USCIS Tightens Vaccination Requirements 2
... Health says many smokers are yet to understand th...warning pictures are an effective// way to get the...r of Health, Damien O'Connor, today launched a pro...ackets. The Ministry wants feedback on whether he...
...ol of Business (ISB) Tuesday signed a memorandum o...derabad-based real estate company, to establish// ...n studies'. This is said to be the first such st...chool in India. It is also the first research cha...
... found a gene that increased Type 2 diabetes in ov...d new treatment for the condition in humans. // T...ition, with an estimated 16 million Americans affl...en, the development of the disease is caused by ob...
...high on fiber is perhaps the first thing that doct...offsetting hemorrhoids. // Hemorrhoids, a conditio...n and around the anus that can give rise to bleedi...erican Society of Colon and Rectal Surgeons, hemor...
Other Medicine News:Health News:New Zealand To Issue Graphic Warnings In Cigarette Packs 2
(Date:7/23/2008)...apy to Treat the Disease -, WAYNE, N.J. and EMERY...ayer HealthCare Pharmaceuticals and Onyx Pharmaceu...he New England Journal of Medicine published,resul...) (sorafenib),tablets decreased the absolute risk ...le hepatocellular carcinoma (HCC), or liver cancer...
(Date:7/23/2008)...e/ -- The following was,released by the U.S. Depar...er Smith, and Members of the Committee.,Thank you ...peared before this Committee almost six months ago...lented and dedicated professionals,at the Justice ...ome to,appreciate that much more deeply their serv...
(Date:7/23/2008)...Code BioPharmaceutics, Inc.,an emerging biopharma...,results demonstrating the utility of their lead d...chronic blood disorder paroxysmal nocturnal,hemogl...nted at the XXII,International Complement Workshop...only treatment currently available for PNH patient...
(Date:7/22/2008)...FirstCall/ -- Following a,thorough review that con...euticals Limited (ASX: PGL; Nasdaq: PGLA) today an... study in liver cancer. Progen confirmed,its strat...f compounds and,the company will actively seek to ...ough Merger & Acquisition activity., The strategi...
Breaking Medicine Technology:The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3New Lung Association Study Shows 24142 Billion Benefit of Converting to Zero Emission Vehicles by 2030 14836 1New Lung Association Study Shows 24142 Billion Benefit of Converting to Zero Emission Vehicles by 2030 14836 2New Lung Association Study Shows 24142 Billion Benefit of Converting to Zero Emission Vehicles by 2030 14836 3New Lung Association Study Shows 24142 Billion Benefit of Converting to Zero Emission Vehicles by 2030 14836 4NHS Choices Launches New Fitness Section 14834 1Admins Support 65 25 More Pharma Operations Execs than Rule of Thumb Dictates 14832 1Admins Support 65 25 More Pharma Operations Execs than Rule of Thumb Dictates 14832 2Monkey Brain Gives Clues to Human Interaction 14831 1Monkey Brain Gives Clues to Human Interaction 14831 2
.../PRNewswire/ -- Novagali Pharma, an,emerging ophth...lmology, announces today positive results from the...n suffering from Vernal,Keratoconjunctivitis (VKC)...ymptoms and signs of disease improved in patients,...y to Vekacia(R),was excellent. , VKC is a severe f...
...Apr 4, 2007 - CytRx Corporation,(NASDAQ:CYTR) toda...stroke studies indicating that CytRx,s lead drug c... recovery of sensory and,motor function in an expe...was withheld as long as 48 hours after stroke was,...nical data,announced by CytRx in December 2006. Or...
Other Medicine Technology:Novagali Pharma Announces Positive Vekacia Clinical Results From,Pivotal Phase III Trial in Vernal Keratoconjunctivitis 2CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 2CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 3CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 4CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 5
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations.
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations.
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations.
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations.
Medicine Products: